We are live on ! Find out more
OCM

Opti Capital Management Portfolio holdings

AUM $1.64B
1-Year Est. Return 0%
This Fund
S&P 500
This Quarter Est. Return
-0%
1 Year Est. Return
0%
3 Year Est. Return
-0.01%
5 Year Est. Return
+0.33%
10 Year Est. Return
AUM
$2.23B
AUM Growth
+$528M
Cap. Flow
-$1.46B
Cap. Flow %
-65.47%
Top 10 Hldgs %
44.57%
Holding
66
New
2
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
GOSS icon
Gossamer Bio
GOSS
+$156K
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$101K

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 99.99%
2 Healthcare 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
1
Gossamer Bio
GOSS
$83.2M
$165K 0.01%
+182,319
New +$156K
KPTI icon
2
Karyopharm Therapeutics
KPTI
$42.4M
$84.5K ﹤0.01%
+8,333
New +$101K

Similar funds

Opti Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Opti Capital Management held 66 positions worth $2.23B, up 31% from $1.71B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Opti Capital Management withdrew a net $1.46B in Q4 2024.

By sector, the portfolio is most concentrated in Miscellaneous at 100% of assets, followed by Healthcare.

Against the trend, Opti Capital Management opened a new position in Gossamer Bio worth $165K.

  • Opti Capital Management's largest Q4 2024 buy was Gossamer Bio: 182,319 shares worth $165K.
  • Opti Capital Management's ten largest holdings make up 45% of its $2.23B portfolio in Q4 2024.
  • Opti Capital Management opened 2 new positions and closed 0 in Q4 2024.
  • Opti Capital Management's portfolio value rose 31% quarter-over-quarter to $2.23B.

Based on Opti Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.